Literature DB >> 14746908

Intramuscular plasmid DNA electrotransfer: biodistribution and degradation.

M F Bureau1, S Naimi, R Torero Ibad, J Seguin, C Georger, E Arnould, L Maton, F Blanche, P Delaere, D Scherman.   

Abstract

We have studied radiolabelled plasmid DNA biodistribution and degradation in the muscle at different times after injection, with or without electrotransfer using previously defined conditions. Radiolabelled plasmid progressively left the muscle and was degraded as soon as 5 min after plasmid injection, with or without electrotransfer. Autoradiography showed that the major part of injected radioactivity was detected in the interfibrilar space of a large proportion of the muscle. Large zones of accumulation of radioactivity, which seems to be contained in some fibres (more than 20 microm), were identified as soon as 5 min after electrotransfer. Such structures were never observed on slices of non-electrotransferred muscles. However, these structures were not frequent and probably lesional. The surprising fact is that despite the amount of intact plasmid having been greatly reduced between 5 min and 3 h after injection, the level of transfection remains unchanged whether electric pulses were delivered 20 s or 3 h after injection. Such a behavior was similarly observed when injecting 0.3, 3 or 30 microg of plasmid DNA. Moreover, the transfection level was correlated to the amount of plasmid DNA injected. These results suggest that as soon as it is injected, plasmid DNA is proportionally partitioned between at least two compartments. While a major part of plasmid DNA is rapidly cleared and degraded, the electrotransferable pool of plasmid DNA represents a very small part of the amount injected and belongs to another compartment where it is protected from endogenous DNAses.

Mesh:

Substances:

Year:  2004        PMID: 14746908     DOI: 10.1016/j.bbaexp.2003.11.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Gene transfer: how can the biological barriers be overcome?

Authors:  Jean-Michel Escoffre; Justin Teissié; Marie-Pierre Rols
Journal:  J Membr Biol       Date:  2010-07-10       Impact factor: 1.843

2.  Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Authors:  Vivek Mahajan; Zagit Gaymalov; Daria Alakhova; Richa Gupta; Irving H Zucker; Alexander V Kabanov
Journal:  Biomaterials       Date:  2015-10-09       Impact factor: 12.479

3.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

Review 4.  What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues.

Authors:  Jean-Michel Escoffre; Thomas Portet; Luc Wasungu; Justin Teissié; David Dean; Marie-Pierre Rols
Journal:  Mol Biotechnol       Date:  2008-11-18       Impact factor: 2.695

5.  Optimization of an electroporation protocol using the K562 cell line as a model: role of cell cycle phase and cytoplasmic DNAses.

Authors:  Andrés Delgado-Cañedo; Daniel Garcia Dos Santos; José Artur Bogo Chies; Kátia Kvitko; Nance Beyer Nardi
Journal:  Cytotechnology       Date:  2006-11-14       Impact factor: 2.058

6.  Current Progress in Electrotransfection as a Nonviral Method for Gene Delivery.

Authors:  Lisa D Cervia; Fan Yuan
Journal:  Mol Pharm       Date:  2018-06-20       Impact factor: 4.939

7.  Quantitative evaluation of DNA dissociation from liposome carriers and DNA escape from endosomes during lipid-mediated gene delivery.

Authors:  Salomé Magalhães; Sofia Duarte; Gabriel A Monteiro; Fábio Fernandes
Journal:  Hum Gene Ther Methods       Date:  2014-10       Impact factor: 2.396

8.  Novel pentablock copolymers for selective gene delivery to cancer cells.

Authors:  Bingqi Zhang; Mathumai Kanapathipillai; Paul Bisso; Surya Mallapragada
Journal:  Pharm Res       Date:  2009-01-14       Impact factor: 4.200

Review 9.  FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

Authors:  Dennis M Klinman; Sven Klaschik; Debra Tross; Hidekazu Shirota; Folkert Steinhagen
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

Review 10.  Physical methods for intracellular delivery: practical aspects from laboratory use to industrial-scale processing.

Authors:  J Mark Meacham; Kiranmai Durvasula; F Levent Degertekin; Andrei G Fedorov
Journal:  J Lab Autom       Date:  2013-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.